These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14234753)

  • 21. RETENTION, TRANSLOCATION, AND EXCRETION OF PU-239 02. HW-76000.
    BAIR WJ
    HW SA US At Energy Comm; 1963 Jan; 86():126-35. PubMed ID: 24547057
    [No Abstract]   [Full Text] [Related]  

  • 22. THE METABOLISM OF BIOLOGICALLY IMPORTANT RADIONUCLIDES. IV. THE METABOLISM OF TRANSURANIC ELEMENTS.
    TAYLOR DM
    Br J Radiol; 1964 Feb; 37():95-100. PubMed ID: 14120798
    [No Abstract]   [Full Text] [Related]  

  • 23. THE DISTRIBUTION OF 239PU IN THE BODY FOLLOWING EXPOSURE BY INHALATION.
    SNYDER WS
    Health Phys; 1964 Dec; 10():1035-42. PubMed ID: 14244749
    [No Abstract]   [Full Text] [Related]  

  • 24. EXCRETION OF PLUTONIUM INTO THE PERFUSED RAT INTESTINE. HW-76000.
    BALLOU JE
    HW SA US At Energy Comm; 1963 Jan; 86():18-21. PubMed ID: 24547068
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of DTPA on excretion and tissue distribution of injected 238Pu in fed and fasting rats.
    Sanders CL; Meier DM
    Health Phys; 1973 Oct; 25(4):405-11. PubMed ID: 4785417
    [No Abstract]   [Full Text] [Related]  

  • 26. EXCRETION OF PU-239 INTO THE INTESTINE. HW-80500.
    BALLOU JE; SULLIVAN MF
    HW SA US At Energy Comm; 1964 Jan; 18():116-9. PubMed ID: 24551946
    [No Abstract]   [Full Text] [Related]  

  • 27. Intracellular plutonium: removal by liposome-encapsulated chelating agent.
    Rahman YE; Rosenthal MW; Cerny EA
    Science; 1973 Apr; 180(4083):300-2. PubMed ID: 4633691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation of skeletal plutonium levels based on DPTA-induced radionuclide excretion in feces: possible application to man.
    Bhattacharyya MH; Guilmette RA; Peterson DP; Chao FC; Lindinbaum A
    Health Phys; 1978 Jun; 34(6):549-55. PubMed ID: 730507
    [No Abstract]   [Full Text] [Related]  

  • 29. Removal of polymeric plutonium from dogs with DTPA and glucan.
    Rosenthal MW; Lindenbaum A; Baxter DW; Kalesperis GS; Moretti ES; Russell JJ
    Radiat Res; 1975 Aug; 63(2):253-61. PubMed ID: 1096228
    [No Abstract]   [Full Text] [Related]  

  • 30. [Acceleration of the excretion of monomeric 239Pu-citrate from the body as effected by pentacyne encapsulated in liposomes].
    Il'in LA; Smirnov AA; Ivannikov AT; Parfenova IM
    Vopr Med Khim; 1983; 29(4):109-12. PubMed ID: 6353751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WHOLE-BODY IRRADIATION IN THE YOUNG PIG: GROWTH, HEMATOLOGY, AND METABOLISM OF CALCIUM-45 AND STRONTIUM-89.
    LOWREY RS; BELL MC
    Radiat Res; 1964 Dec; 23():580-93. PubMed ID: 14240217
    [No Abstract]   [Full Text] [Related]  

  • 32. EVALUATION OF PLUTONIUM EXPOSURES IN MAN.
    ROBERTSON JS; COHN SH
    Health Phys; 1964 Jun; 10():373-89. PubMed ID: 14168593
    [No Abstract]   [Full Text] [Related]  

  • 33. Developing a physiologically based approach for modeling plutonium decorporation therapy with DTPA.
    Kastl M; Giussani A; Blanchardon E; Breustedt B; Fritsch P; Hoeschen C; Lopez MA
    Int J Radiat Biol; 2014 Nov; 90(11):1062-7. PubMed ID: 24844369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DTPA-Coated Liposomes as a New Delivery Vehicle for Plutonium Decorporation.
    Grémy O; Mougin-Degraef M; Devilliers K; Berdal M; Laroche P; Miccoli L
    Radiat Res; 2021 Jan; 195(1):77-92. PubMed ID: 33180911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic and therapeutic studies of plutonium. IV. ANL-7535.
    Lindenbaum A; Rosenthal MW; Lund CJ; Russell JJ; Smoler MH; Moretti ES; Brown H
    ANL Rep; 1968 Dec; ():60-5. PubMed ID: 5306872
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis and therapeutic testing of mono- and dialkyl esters of pentetic (diethylenetriaminepentaacetic) acid for decorporation of polymeric plutonium.
    Guilmette RA; Parks JE; Lindenbaum A
    J Pharm Sci; 1979 Feb; 68(2):194-6. PubMed ID: 423090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EFFECT OF DESFERRIOXAMINE B-METHANE SULFONATE (DFOM) ON REMOVAL OF PLUTONIUM IN VITRO AND IN VIVO.
    ROSENTHAL MW; LINDENBAUM A
    Proc Soc Exp Biol Med; 1964 Dec; 117():749-50. PubMed ID: 14244943
    [No Abstract]   [Full Text] [Related]  

  • 38. Removal of polymeric plutonium by DTPA directed into cells by liposome encapsulation.
    Rosenthal MW; Rahman YE; Moretti ES; Cerny EA
    Radiat Res; 1975 Aug; 63(2):262-74. PubMed ID: 1144691
    [No Abstract]   [Full Text] [Related]  

  • 39. INTERACTIONS IN THE METABOLISM OF PU-239 AND NP-239. HW-80500.
    SMITH VH
    HW SA US At Energy Comm; 1964 Jan; 18():73-5. PubMed ID: 24547246
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of plutonium systemic distribution in rats and dogs with published data in humans.
    Melo DR; Weber W; Doyle-Eisele M; Guilmette RA
    Int J Radiat Biol; 2014 Nov; 90(11):1025-9. PubMed ID: 24669776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.